Inventor · disambiguated record
Michael G. Yang
Also filed as: MITCHELL IAN S · YANG MICHAEL G · YANG MICHAEL GUANG
47 granted patents·15 pending applications·1,107 citations·filing 1998–2025
98Inventor score
Files withBRISTOL MYERS SQUIBB CO32BRISTOL MYERS SQUIBB PHARMA CO20ARIAD PHARMA INC3BRISTOL MYERS SQIBB PHARMA COM2DU PONT PHARM CO2
Top patents by PatentIndex Score
62 records- 0198US7183282B2Substituted heterocycle fused γ-carbolinesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2006·Granted Feb 27, 2007·145 cites·4 claims
- 0298US6552017B1Substituted heterocycle fused gamma-carbolinesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Apr 22, 2003·208 cites·21 claims
- 0397USRE39680ESubstituted heterocycle fused gamma-carbolinesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2006·Granted Jun 5, 2007·142 cites·21 claims
- 0497USRE39679ESubstituted heterocycle fused gamma-carbolinesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2006·Granted Jun 5, 2007·129 cites·33 claims
- 0597US7071186B2Substituted heterocycle fused gamma-carbolinesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2004·Granted Jul 4, 2006·121 cites·15 claims
- 0695US11767322B2Triazolopyridinyl compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Sep 26, 2023·3 cites·66 claims
- 0795US11021462B2Sulfone pyridine alkyl amide-substituted heteroaryl compoundsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jun 1, 2021·6 cites·28 claims
- 0894US11787779B2Sulfone pyridine alkyl amide-substituted heteroaryl compoundsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Oct 17, 2023·2 cites·4 claims
- 0993US7498324B2Substituted lactams as inhibitors of Aβ protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2007·Granted Mar 3, 2009·18 cites·39 claims
- 1093US7390896B2Cyclic malonamides as inhibitors of Aβ protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2007·Granted Jun 24, 2008·17 cites·27 claims
- 1192US10294256B2Phosphine oxide alkyl amide substituted heteroaryl compounds as modulators of IL-12, IL-23 and/or IFN alpha responsesBRISTOL MYERS SQUIBB CO·Filed 2017·Granted May 21, 2019·5 cites·10 claims
- 1292US7528249B2Cyclic malonamides as inhibitors of aβ protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2008·Granted May 5, 2009·13 cites·13 claims
- 1392US7390802B2Substituted lactams as inhibitors of Aβ protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2007·Granted Jun 24, 2008·17 cites·36 claims
- 1492US7276496B2Cyclic malonamides as inhibitors of Aβ protein protectionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2006·Granted Oct 2, 2007·13 cites·20 claims
- 1591US7655647B2Substituted lactams as inhibitors of Aβ protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2009·Granted Feb 2, 2010·13 cites·8 claims
- 1691US6759404B2Cyclic malonamides as inhibitors of aβ protein productionFiled 2001·Granted Jul 6, 2004·27 cites·40 claims
- 1790US10435369B2Tricyclic sulfones as ROR gamma modulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Oct 8, 2019·6 cites·6 claims
- 1889US7163937B2Cyclic derivatives as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Jan 16, 2007·29 cites·19 claims
- 1989US7001901B2Tetrazolylpropionamides as inhibitors of Aβ protein productionBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Feb 21, 2006·23 cites·15 claims
- 2089US6632812B2Substituted lactams as inhibitors of Aβ protein productionDU PONT PHARM CO·Filed 2001·Granted Oct 14, 2003·25 cites·27 claims
- 2186US12365667B2Sulfone pyridine alkyl amide-substituted heteroaryl compoundsBRISTOL MYERS SQUIBB CO·Filed 2023·Granted Jul 22, 2025·0 cites·13 claims
- 2285US7053081B2Cyclic malonamides as inhibitors of A-β protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2003·Granted May 30, 2006·13 cites·20 claims
- 2384US7482335B2Cyclic derivatives as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jan 27, 2009·6 cites·21 claims
- 2484US7276495B2Substituted lactams as inhibitors of Aβ protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2004·Granted Oct 2, 2007·13 cites·60 claims
- 2584US6900199B2Substituted lactams as inhibitors of Aβ protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2003·Granted May 31, 2005·13 cites·39 claims
- 2684US6482852B2Bicyclic signal transduction inhibitors, compositions containing them & uses thereofARIAD PHARMA INC·Filed 2001·Granted Nov 19, 2002·20 cites·81 claims
- 2783US7629351B2N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-2-oxo-3-(6-(trifluoromethyl)quinazolin-4-ylamino) pyrrolidin-1-yl)cyclohexyl)acetamide and other modulators of chemokine receptor activity, crystalline forms and processBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Dec 8, 2009·5 cites·9 claims
- 2883US6573295B2Bicyclic signal transduction inhibitors, compositions containing them & uses thereofARIAD PHARMA INC·Filed 2001·Granted Jun 3, 2003·17 cites·81 claims
- 2983US2025304555A1Sulfone pyridine alkyl amide-substituted heteroaryl compoundsBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 3082US10166249B2Substituted bicyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jan 1, 2019·2 cites·7 claims
- 3182US7378409B2Substituted cycloalkylamine derivatives as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2004·Granted May 27, 2008·20 cites·9 claims
- 3281US9522888B2Substituted bicyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Dec 20, 2016·2 cites·12 claims
- 3381US7671062B2Modulators of chemokine receptor activity, crystalline forms and processBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Mar 2, 2010·4 cites·9 claims
- 3481US6713476B2Substituted cycloalkyls as inhibitors of a beta protein productionDU PONT PHARM CO·Filed 2001·Granted Mar 30, 2004·17 cites·30 claims
- 3579US12110290B2Triazolopyridinyl compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2023·Granted Oct 8, 2024·0 cites·14 claims
- 3678US11701373B2Substituted bicyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Jul 18, 2023·0 cites·5 claims
- 3778US2024425505A1Triazolopyridinyl compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 3876US11597721B2Heterocyclic compounds comprising pyridine useful as modulators of IL-12, IL-23 and/or IFNα responsesBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Mar 7, 2023·1 cites·11 claims
- 3975US11058696B2Substituted bicyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Jul 13, 2021·0 cites·4 claims
- 4072US10709719B2Substituted bicyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jul 14, 2020·0 cites·10 claims
- 4171US2010041639A1Cyclic malonamides as inhibitors of a beta protein productionBRISTOL MYERS SQIBB PHARMA COM·Filed 2009·Application pending·0 cites
- 4270US2010009965A1Cyclic malonamides as inhibitors of abeta protein productionBRISTOL MYERS SQIBB PHARMA COM·Filed 2009·Application pending·0 cites
- 4369US2009264419A1CYCLIC MALONAMIDES AS INHIBITORS OF Abeta PROTEIN PRODUCTIONBRISTOL MYERS SQUIBB PHARMA CO·Filed 2009·Application pending·0 cites
- 4467US6576766B1Signal transduction inhibitors, compositions containing themARIAD PHARMA INC·Filed 1998·Granted Jun 10, 2003·12 cites·73 claims
- 4567US2010048541A1Substituted lactams as inhibitors of abeta protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2009·Application pending·0 cites
- 4667US2010009966A1Substituted lactams as inhibitors of abeta protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2009·Application pending·0 cites
- 4767US2010056501A1Substituted lactams as inhibitors of abeta protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2009·Application pending·0 cites
- 4867US2010069373A1Substituted lactams as inhibitors of a beta protein productionBRISTOL MYERS SQUIBB PHARMA CO·Filed 2009·Application pending·0 cites
- 4963US7829571B2Cyclic derivatives as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Nov 9, 2010·0 cites·18 claims
- 5063US2025084056A1Substituted oxoisoindolinyl piperidine-2,6-dione compoundsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
Showing the top 50 of 62 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →